In transgenic mice bearing amyloid precursor protein (APP) overexpression, and point mutations of PS1 and tau genes, models of familiar AD, temsirolimus contrasted brain deposition of insoluble aggregates of Aβ and phosphorylated tau, lowering the amount of neurofibrillary tangle and apoptotic neurons. Here, PSEN1 is linked to Alzheimer disease.